Novavax Covid-19 vaccine induces immune response in early study

Novavax research chief Gregory Glenn said the late-stage clinical trial of the experimental Covid-19 vaccine could potentially glean enough data to obtain regulatory approvals as early as December.

from Hindustan Times - world https://ift.tt/3gpxljU
via IFTTT